Figure 5.
Figure 5. BCLXL is the major factor that limits MM cell death to the pharmacological inhibition of MCL1. (A) After transfection with scramble or BCLXL-specific siRNA, MM1S, LP1, and U266 HMCLs were treated with A1210477 (5 μM) for 24 hours, cell death was assessed by Annexin V staining and the induction of apoptosis was compared with the non-treated controls. Results represent the mean ± SD of 5 independent experiments. Statistical analysis was performed using Student t-Test. (B) Combination of A1210477 and A1155463 overcomes A1210477 resistance in LP1 and U266 HMCLs. LP1 and U266 HMCLs were treated with combination of low doses of both A1210477 (3 and 4 μM) and A1155463 (100, 300 and 500 nM). All data points represent the mean of triplicate experiments ± SD. Combination index (CI) was calculated using CalcuSyn software.

BCLXL is the major factor that limits MM cell death to the pharmacological inhibition of MCL1. (A) After transfection with scramble or BCLXL-specific siRNA, MM1S, LP1, and U266 HMCLs were treated with A1210477 (5 μM) for 24 hours, cell death was assessed by Annexin V staining and the induction of apoptosis was compared with the non-treated controls. Results represent the mean ± SD of 5 independent experiments. Statistical analysis was performed using Student t-Test. (B) Combination of A1210477 and A1155463 overcomes A1210477 resistance in LP1 and U266 HMCLs. LP1 and U266 HMCLs were treated with combination of low doses of both A1210477 (3 and 4 μM) and A1155463 (100, 300 and 500 nM). All data points represent the mean of triplicate experiments ± SD. Combination index (CI) was calculated using CalcuSyn software.

Close Modal

or Create an Account

Close Modal
Close Modal